Beneficial Effect of Flecainide Controlled Release on the Quality of Life of Patients with Atrial Fibrillation-the REFLEC-CR Study.
Title | Beneficial Effect of Flecainide Controlled Release on the Quality of Life of Patients with Atrial Fibrillation-the REFLEC-CR Study. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Tzeis, S., Tsiachris D., Asvestas D., Kourouklis S., Patsourakos F., Karlis D., Kouskos G., Papadimitriou G., Gavriilidou M., Vatkalis N., Kapetanios K., Koufaki P., Taxiarchou E., & Giannakoulas G. |
Corporate Authors | REFLEC-CR study investigators |
Journal | Cardiovasc Drugs Ther |
Volume | 34 |
Issue | 3 |
Pagination | 383-389 |
Date Published | 2020 06 |
ISSN | 1573-7241 |
Keywords | Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Delayed-Action Preparations, Female, Flecainide, Heart Rate, Humans, Male, Medication Adherence, Middle Aged, Patient Safety, Prospective Studies, Quality of Life, Time Factors, Treatment Outcome |
Abstract | PURPOSE: Atrial fibrillation (AF) is the most common cardiac arrhythmia with a considerable impact on patients' quality of life (QoL). |
DOI | 10.1007/s10557-020-06971-5 |
Alternate Journal | Cardiovasc Drugs Ther |
PubMed ID | 32236859 |